Related Experiment Video

Updated: Jul 16, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Hemodynamic changes during cardiac resynchronization therapy

H Nägele1, M Azizi, M A Castel

  • 1Medizinische Klinik, Krankenhaus Reinbek, St. Adolfstift, Hamburger Str. 41, D-21465 Reinbek. naegele@uke.uni-hamburg.de

Clinical Cardiology
|March 28, 2007
PubMed

Insights

Cardiac resynchronization therapy (CRT) improves central hemodynamics in heart failure patients. This study found reduced pressures and improved cardiac function six months after CRT device implantation.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) is an emerging treatment for heart failure patients with conduction delays.
  • The long-term effects of CRT on central hemodynamics require further investigation.

Purpose of the Study:

  • To evaluate the impact of CRT on central hemodynamics in heart failure patients.
  • To assess changes in cardiac function and pressures six months post-CRT implantation.

Main Methods:

  • Right heart catheterization was performed on 31 heart failure patients before and 6 months after CRT device implantation.
  • Hemodynamic parameters, including pressures and vascular resistance, were measured at rest and during exercise (25 watts).
  • Left ventricular ejection fraction (LVEF) and brain natriuretic peptide (BNP) levels were also assessed.

Main Results:

  • Patients showed significant improvements in NYHA functional class and LVEF post-CRT.
  • Reduced right atrial (RA), pulmonary artery (PA), and pulmonary capillary wedge (PCW) pressures were observed.
  • Pulmonary vascular resistance, heart rate, and mean arterial pressure also showed favorable changes.
  • Brain natriuretic peptide (BNP) levels decreased, indicating reduced cardiac strain.

Conclusions:

  • CRT significantly improves central hemodynamics in heart failure patients.
  • The therapy leads to enhanced cardiac function and reduced filling pressures six months after implantation.
  • CRT offers benefits beyond ventricular coordination, positively impacting overall cardiovascular status.

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Related Concept Videos

Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart rate...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...